Question

Difficulty: HardPharmacokinetic and Pharmacodynamic Principles

A physician is reviewing medication safety protocols for a hospital's Pharmacy and Therapeutics Committee. Various clinical scenarios are presented that highlight critical alterations in pharmacokinetics, requiring specific dosing strategies or medication substitutions to prevent severe adverse events. Match each high-risk clinical scenario with its primary underlying pharmacokinetic mechanism.

  • Initiation of standard-dose oral morphine in a patient with Child-Pugh Class C cirrhosisMarkedly increased systemic bioavailability due to impaired hepatic first-pass extraction and portosystemic shunting
  • Administration of intravenous ceftriaxone to a two-day-old neonate with severe jaundiceCompetitive displacement from plasma proteins leading to an increased free fraction of a potentially toxic endogenous compound
  • Prescribing a standard adult maintenance dose of digoxin to an 82-year-old female with profound sarcopenia and a serum creatinine of 0.8 mg/dLDrug accumulation due to age-related decline in glomerular filtration rate that is not reflected by standard serum surrogate markers
  • Co-administration of oral ciprofloxacin with an over-the-counter calcium carbonate antacidFormation of an insoluble coordination complex in the gastrointestinal tract resulting in significantly decreased drug absorption

Answer

The correct matches pair each clinical scenario with its defining ADME (Absorption, Distribution, Metabolism, Excretion) alteration: Morphine in cirrhosis involves impaired first-pass metabolism; Ceftriaxone in neonates involves protein-binding displacement; Digoxin in the elderly involves masked renal impairment; and Ciprofloxacin with calcium involves decreased absorption via chelation.
Each scenario represents a core pharmacokinetic vulnerability across the ADME spectrum: (1) Metabolism: Morphine's oral bioavailability is normally low due to high hepatic extraction, which is critically lost in cirrhosis. (2) Distribution: Ceftriaxone shares albumin binding sites with bilirubin, displacing it and causing toxicity. (3) Excretion: Digoxin requires renal clearance, which is predictably reduced in the elderly despite normal creatinine levels due to sarcopenia. (4) Absorption: Ciprofloxacin undergoes chelation in the gut when exposed to polyvalent cations like calcium.

Step-by-Step Solution

1
Analyze the morphine/cirrhosis scenario
Matches with impaired hepatic first-pass extraction
Cirrhosis causes portosystemic shunting and hepatocyte loss, bypassing hepatic extraction and massively increasing the bioavailability of drugs with high first-pass metabolism like morphine.
2
Analyze the ceftriaxone/neonate scenario
Matches with competitive displacement from plasma proteins
Ceftriaxone displaces bilirubin from albumin binding sites, increasing the free fraction of bilirubin and risking kernicterus in vulnerable neonates.
3
Analyze the digoxin/elderly scenario
Matches with age-related decline in glomerular filtration rate masking by surrogate markers
Sarcopenia in the elderly reduces creatinine production, falsely normalizing serum creatinine despite poor actual renal clearance, leading to accumulation of renally excreted drugs like digoxin.
4
Analyze the ciprofloxacin/antacid scenario
Matches with formation of an insoluble coordination complex
Polyvalent cations in antacids bind to fluoroquinolones in the gastrointestinal tract, forming chelates that prevent systemic absorption.

Key Concept

Pharmacokinetic ADME Principles in Special Populations and Drug Interactions
Rate this question